
Friday Dec 21, 2018
Biotech strategy and nanomedicine: the pharmaphorum podcast
For episode 5 of the pharmaphorum podcast Dominic Tyer met Blueberry Therapeutics’ CEO Dr John Ridden at The Wellcome Collection in London to talk about the UK biotech he co-founded, its strategy and bringing innovation to life through Blueberry’s nanomedicine approach.
No comments yet. Be the first to say something!